SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Leiomyosarcoma
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
smooth muscle malignant tumor
acanthosis nigricans (hyperpig and epidermal thickening)
paraneoplastic effects of leukemias and lymphomas
2. Skin (SqCC) - liver (angiosarcoma)
Leading cause of death in the US
arsenic target
p16 gene
Irreversible - plasias
3. Lung - liver - intestine or following reperfusion.
Red (hemorrhagic) infarcts
Leading cause of death in the US
smooth muscle malignant tumor
c - myc gene
4. Antibodies to presynaptic Ca2+ channels at NM junction
asbestos target
secondary amyloidosis (reactive systemic)
paraneoplastic effects of thymoma - small cell lung carcinoma
NF1 gene
5. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
Leukocyte extravasation: rolling
granulomatous disease
NF2 gene
abl gene
6. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
blood cell malignant tumors
c - kit gene
causes of decreased ESR
alpha - fetoprotein
7. Heart disease
bcl -2 gene
Leading cause of death in the US
granulomatous disease
TRAP
8. Vascular: ICAM-1 Leukocyte: LFA-1 (integrin)
arsenic target
Reversible - plasias
Where you see Psammoma bodies
Leukocyte extravasation: tight binding
9. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
aflatoxin target
Neoplasm associated with xeroderma pigmentosum (albinism)
blood vessels benign tumor
PSA
10. Liver (angiosarcoma)
vinyl chloride target
immunodeficiency states
Leukocyte extravasation: diapedesis
L- myc gene
11. Lipoma
fat benign tumor
Paget's bone disease
DPC gene
immunodeficiency states
12. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
lung cancer incidence/mortality
Irreversible - plasias
malignant epithelial tumor
alpha - fetoprotein
13. ACTH or ACTH- like peptide
CCl4 target
skeletal muscle malignant tumor
paraneoplastic effects of small cell lung carcinoma
Barrett's esophagus (chronic GI reflux)
14. Membrane lipid peroxidation - protein modification and DNA breakage.
erb - B2 gene
Free radical cell damage
S-100
blood vessels malignant tumor
15. Tumor marker: melanoma - neural tumors - astrocytomas
PSA
S-100
c - kit gene
CEA
16. Tumor marker: mets to bone - obstructive biliary disease - Paget's
abl gene
cigarette smoke target
Alk - phos
Chronic inflammatory mediators
17. 32%/18% female
Second - leading cause of death in the US
breast cancer incidence/mortality
blood vessels malignant tumor
erb - B2 gene
18. Colorectal cancer (assoc with FAP) 5q tumor suppressor
NF2 gene
APC gene
Resolution of inflammation
radiation exposure
19. Infections - inflammation - cancer - pregnancy - SLE
causes of increased ESR
Leading cause of death in the US
Alkylating agents target
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
20. All - AML
Rb gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
Neoplasm associated with Down Syndrome
CA-19-9
21. Adenoma - papilloma
Leukocyte extravasation: migration
benign >1 cell type tumor
benign epithelial tumor
Primary tumors that met to brain
22. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
Primary tumors that met to bone
Napthalene (aniline) dyes target
benign >1 cell type tumor
Resolution of inflammation
23. PTH- related peptide - TGF- beta - TNF - IL-1
beta - hCG
smooth muscle benign tumor
extrinsic apoptosis
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
24. Squamous cell carcinoma of skin
iron poisoning
WT1 gene
asbestos target
Neoplasm associated with actinic keratosis
25. Tumor marker: pancreatic adenocarcinoma
CA-19-9
malignant epithelial tumor
fat malignant tumor
Neoplasm associated with xeroderma pigmentosum (albinism)
26. Larynx (SqCC) - lung (SqCC and SCC) - kidney (renal cell carcinoma) - bladder (transitional cell carcinoma)
ras gene
primary amyloidosis
fat benign tumor
cigarette smoke target
27. Rhabdomyosarcoma
Red (hemorrhagic) infarcts
Prostatic acid phosphatase
paraneoplastic effects of leukemias and lymphomas
skeletal muscle malignant tumor
28. Angiosarcoma
blood vessels malignant tumor
Leading cause of death in the US
blood cell malignant tumors
iron poisoning
29. Esophagus - stomach
Free radical cell damage
Where you see Psammoma bodies
nitrosamines (smoked foods) target
Second - leading cause of death in the US
30. Secondary osteosarcoma and fibrosarcoma
Warning
: Invalid argument supplied for foreach() in
/var/www/html/basicversity.com/show_quiz.php
on line
183
31. Liver (hepatocellular carcinoma)
fat malignant tumor
APC gene
aflatoxin target
CA-125
32. MEN type II and III tyrosine kinase (oncogene)
acanthosis nigricans (hyperpig and epidermal thickening)
erb - B2 gene
ret gene
Primary tumors that met to liver
33. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
DPC gene
malignant >1 cell type tumor
arsenic target
erb - B2 gene
34. Tumor marker: prostate carcinoma marker.
Prostatic acid phosphatase
Primary tumors that met to bone
Barrett's esophagus (chronic GI reflux)
ret gene
35. AA
extrinsic apoptosis
secondary amyloidosis (reactive systemic)
Neoplasm associated with actinic keratosis
bone benign tumor
36. Hemangioma
Leukocyte extravasation: rolling
blood vessels benign tumor
smooth muscle benign tumor
benign epithelial tumor
37. Leiomyoma
TRAP
paraneoplastic effects of small cell lung carcinoma
nitrosamines (smoked foods) target
smooth muscle benign tumor
38. Melanoma 9p tumor suppressor
Reversible - plasias
BRAC2 gene
p16 gene
Leukocyte extravasation: tight binding
39. PECAM-1
prostate cancer incidence/mortality
blood vessels malignant tumor
Leukocyte extravasation: diapedesis
Chronic inflammatory mediators
40. Vascular: E and P- selectin Leukocyte: Sialyl Lewis
Leukocyte extravasation: rolling
Leukocyte extravasation: tight binding
CA-19-9
blood cell malignant tumors
41. Liposarcoma
BRCA1 gene
intrinsic apoptosis
benign epithelial tumor
fat malignant tumor
42. Tumor marker: neuroblastoma - lung and gastric cancer
ras gene
N- myc gene
L- myc gene
Bombesin
43. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
Primary tumors that met to liver
DCC gene
Leukocyte extravasation: tight binding
beta - hCG
44. AL
primary amyloidosis
AIDS
Second - leading cause of death in the US
Barrett's esophagus (chronic GI reflux)
45. Malignant lymphoma
immunodeficiency states
BRCA1 gene
c - myc gene
beta - hCG
46. Tumor marker: carcinoembryonic Ag Very nonspecific
c - myc gene
Where you see Psammoma bodies
CEA
benign >1 cell type tumor
47. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
ulcerative colitis
NF2 gene
bone malignant tumor
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
48. Adenocarcinoma - papillary carcinoma
malignant epithelial tumor
PSA
Neoplasm associated with Down Syndrome
Neoplasm associated with xeroderma pigmentosum (albinism)
49. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
S-100
Autoimmune (Hashimoto's - myasthenia gravis)
ulcerative colitis
beta - hCG
50. Tumor marker: tartrate - resistant acid phosphatase. Hairy cell leukemia (B- cell neoplasm)
bcl -2 gene
TRAP
ret gene
Red (hemorrhagic) infarcts